Portage Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Portage Biotech has a total shareholder equity of $31.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $49.0M and $17.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$5.34m |
Equity | US$31.33m |
Total liabilities | US$17.71m |
Total assets | US$49.04m |
Financial Position Analysis
Short Term Liabilities: PRTG's short term assets ($7.5M) exceed its short term liabilities ($2.7M).
Long Term Liabilities: PRTG's short term assets ($7.5M) do not cover its long term liabilities ($15.0M).
Debt to Equity History and Analysis
Debt Level: PRTG is debt free.
Reducing Debt: PRTG has no debt compared to 5 years ago when its debt to equity ratio was 2.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PRTG has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PRTG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 44.1% each year